[Clinical study of gene therapy for adenosine deaminase deficiency]

Genetic and phenotypic profile of 112 patients with X-linked Charcot-Marie-Tooth disease type 1.

European journal of neurology·2018

Alanyl-tRNA synthetase mutation in a family with dominant distal hereditary motor neuropathy.

Neurology·2012

Epstein-barr-virus hypersensitivity of lymphocytes from patients with ataxia-telangiectasia.

International journal of oncology·2011

High irradiation sensitivity of epstein-barr-virus (ebv) in lymphoblastoid-cells from patients with ataxia-telangiectasia and ebv genome-positive burkitts-lymphoma.

International journal of oncology·2011

Oxidized low-density lipoprotein increases interleukin-8 production in human gingival epithelial cell line Ca9-22.

Journal of periodontal research·2010

Imaging-pathologic correlation in corticobasal degeneration.

AJNR. American journal of neuroradiology·2009

[RECURRENT CUTANEOUS INFECTIONS LEADING TO THE DIAGNOSIS OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION: A CASE REPORT].

Arerugi = [Allergy]·2026

[CHARACTERISTICS OF ASTHMA PATIENTS WITH A FORCED EXPIRATORY VOLUME IN ONE SECOND/FORCED VITAL CAPACITY OF LESS THAN 70% IN A BRONCHODILATOR INHALATION TEST].

Arerugi = [Allergy]·2026

[GRASS POLLEN DISPERSAL, SYMPTOM AND MEDICATION SCORE IN PATIENTS WITH GRASS POLLINOSIS (FIRST REPORT) -INVESTIGATION OF GRASS POLLEN DISPERSAL PERIOD AND REGIONAL CHARACTERISTICS].

Arerugi = [Allergy]·2026

Clinical Efficacy of High-Frequency Deep Repetitive Transcranial Magnetic Stimulation in the Treatment of Depression and the Predictive Role of Baseline Triglyceride Levels: A Randomized Sham-Controlled Trial.

Clinical EEG and neuroscience·2026

Mechanistic Basis and Therapeutic Potential of a Novel TXNIP Inhibitor in Diabetes Treatment.

Journal of medicinal chemistry·2026

Discovery of BRD9 PROTAC/IMiD Bifunctional Molecules as Potent Therapeutics for Hematologic Malignancies.

Journal of medicinal chemistry·2026

First line asciminib in chronic myeloid leukemia: a quest for the "Holy Grail" of tolerability.

Haematologica·2026

Successful treatment of systemic juvenile xanthogranuloma with an ABL2::GAB2 fusion using dasatinib after failure of conventional chemotherapy and MEK inhibition.

Haematologica·2026

Repurposing MK0873 as a non-covalent hTERT-Targeting compound: a proof of concept study.

Frontiers in aging·2026

Related Experiment Videos

[Clinical study of gene therapy for adenosine deaminase deficiency]

Related Concept Videos

Genetic and phenotypic profile of 112 patients with X-linked Charcot-Marie-Tooth disease type 1.

Alanyl-tRNA synthetase mutation in a family with dominant distal hereditary motor neuropathy.

Epstein-barr-virus hypersensitivity of lymphocytes from patients with ataxia-telangiectasia.

High irradiation sensitivity of epstein-barr-virus (ebv) in lymphoblastoid-cells from patients with ataxia-telangiectasia and ebv genome-positive burkitts-lymphoma.

Oxidized low-density lipoprotein increases interleukin-8 production in human gingival epithelial cell line Ca9-22.

Imaging-pathologic correlation in corticobasal degeneration.

[RECURRENT CUTANEOUS INFECTIONS LEADING TO THE DIAGNOSIS OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION: A CASE REPORT].

[CHARACTERISTICS OF ASTHMA PATIENTS WITH A FORCED EXPIRATORY VOLUME IN ONE SECOND/FORCED VITAL CAPACITY OF LESS THAN 70% IN A BRONCHODILATOR INHALATION TEST].

[GRASS POLLEN DISPERSAL, SYMPTOM AND MEDICATION SCORE IN PATIENTS WITH GRASS POLLINOSIS (FIRST REPORT) -INVESTIGATION OF GRASS POLLEN DISPERSAL PERIOD AND REGIONAL CHARACTERISTICS].

Clinical Efficacy of High-Frequency Deep Repetitive Transcranial Magnetic Stimulation in the Treatment of Depression and the Predictive Role of Baseline Triglyceride Levels: A Randomized Sham-Controlled Trial.

Mechanistic Basis and Therapeutic Potential of a Novel TXNIP Inhibitor in Diabetes Treatment.

Discovery of BRD9 PROTAC/IMiD Bifunctional Molecules as Potent Therapeutics for Hematologic Malignancies.

First line asciminib in chronic myeloid leukemia: a quest for the "Holy Grail" of tolerability.

Successful treatment of systemic juvenile xanthogranuloma with an ABL2::GAB2 fusion using dasatinib after failure of conventional chemotherapy and MEK inhibition.

Repurposing MK0873 as a non-covalent hTERT-Targeting compound: a proof of concept study.

Related Experiment Videos

[Clinical study of gene therapy for adenosine deaminase deficiency]

Related Concept Videos

Related Articles